143 related articles for article (PubMed ID: 33773605)
1. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY
J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605
[TBL] [Abstract][Full Text] [Related]
2. Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation.
Kurashige R; Kurashige M; Okada Y; Higuchi K; Yuda S; Hino A; Miyamura T; Ichii M; Fukushima K; Honma K; Takeuchi M; Yokota T; Ishikawa J; Sawada A; Shibayama H; Hosen N; Morii E
Am J Surg Pathol; 2024 Apr; 48(4):395-405. PubMed ID: 38287877
[TBL] [Abstract][Full Text] [Related]
3. Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case report.
Yoshimura Y; Suwabe T; Fujiki A; Kaji D; Asano-Mori Y; Oba Y; Mizuno H; Yamanouchi M; Tanaka K; Hasegawa E; Miki K; Yokoyama T; Namamura Y; Ishii Y; Yamashita S; Kono K; Kinowaki K; Takazawa Y; Sawa N; Ubara Y
Clin Nephrol; 2024 May; 101(5):250-256. PubMed ID: 38329919
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type.
Ergisi M; Ooi B; Salim O; Papalois V
Transplant Rev (Orlando); 2024 Apr; 38(2):100837. PubMed ID: 38430887
[TBL] [Abstract][Full Text] [Related]
5. Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy.
Socié G; Barba P; Barlev A; Sanz J; García-Cadenas I; Chevallier P; Fagioli F; Guzman-Becerra N; Kumar D; Ljungman P; Pigneux A; Sadetsky N; Yáñez San Segundo L; Shadman M; Storek J; Thirumalai D; Xing B; Mohty M
Bone Marrow Transplant; 2024 Jan; 59(1):52-58. PubMed ID: 37865719
[TBL] [Abstract][Full Text] [Related]
6. Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives.
Compagno F; Basso S; Panigari A; Bagnarino J; Stoppini L; Maiello A; Mina T; Zelini P; Perotti C; Baldanti F; Zecca M; Comoli P
Front Immunol; 2020; 11():567020. PubMed ID: 33042147
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of Epstein-Barr Virus detection in the cerebrospinal fluid of patients who underwent hematopoietic stem cell transplantation].
He Y; Ma R; Wang HF; Mo XD; Zhang YY; Lyu M; Yan CH; Wang Y; Zhang XH; Xu LP; Liu KY; Sun XJ; Huang YQ
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):737-741. PubMed ID: 38049317
[No Abstract] [Full Text] [Related]
8. How I treat posttransplant lymphoproliferative disorder.
Amengual JE; Pro B
Blood; 2023 Oct; 142(17):1426-1437. PubMed ID: 37540819
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death ligand 1 expression associated with subtypes of post-transplant lymphoproliferative disorder among pediatric kidney transplant recipients.
Weinberg OK; Pinkus GC; Ramos-Gonzalez GJ; Agur T; Rodig NM
Clin Transplant; 2023 Dec; 37(12):e15134. PubMed ID: 37772613
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus associated colitis in kidney transplant patients: a case series.
Brás AC; Querido S; Mascarenhas A; Mendes R; Verissimo R; Chagas C; Weigert A
Infect Dis (Lond); 2024 May; 56(5):410-415. PubMed ID: 38459811
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant.
Barlev A; Zimmermann H; Guzman-Becerra N; Mehta A; Xing B; Macabeo B; Thivolet M; Brookhart MA
J Med Econ; 2024 May; ():1-10. PubMed ID: 38727527
[No Abstract] [Full Text] [Related]
12. BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cells.
Zhang TT; Cheng RY; Ott AR; Dahl NP; Suchland ER; Stoffers CM; Asher GD; Hou D; Thouvenel CD; Hill TF; Rawlings DJ; James RG
Sci Transl Med; 2024 Apr; 16(742):eadh8846. PubMed ID: 38598616
[TBL] [Abstract][Full Text] [Related]
13. Increased Incidence of Post-transplant Lymphoproliferative Disorder in Autoimmune Liver Disease: An Irish National Experience.
Abu-Shanab A; Ged Y; Ullah N; Houlihan D; McCormick A
J Clin Exp Hepatol; 2018 Mar; 8(1):42-49. PubMed ID: 29743796
[TBL] [Abstract][Full Text] [Related]
14. Post-transplantation Lymphoproliferative Disorder (PTLD): In the Liver Transplant Recipient.
Janeela AM; Fouzia NA; Zachariah UG
J Clin Exp Hepatol; 2024; 14(2):101286. PubMed ID: 38076446
[TBL] [Abstract][Full Text] [Related]
15. T cell posttransplant lymphoproliferative disorder after kidney transplantation progressing to acute liver failure: a case report.
Cho JM; Kim YC; Min S; Kim TM; Lee H
Korean J Transplant; 2023 Dec; 37(4):299-305. PubMed ID: 38057946
[TBL] [Abstract][Full Text] [Related]
16. Post-transplantation lymphoproliferative disorder with gastrointestinal involvement.
Inayat F; Hassan GU; Tayyab GUN; Saif MW
Ann Gastroenterol; 2018; 31(2):248-251. PubMed ID: 29507477
[TBL] [Abstract][Full Text] [Related]
17. A rare case of Epstein-Barr virus mucocutaneous ulcer of the colon.
Osman M; Al Salihi M; Abu Sitta E; Al Hadidi S
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28687701
[TBL] [Abstract][Full Text] [Related]
18. Complete response to switch immunodepression of late-onset post-transplant lymphoproliferative disease (PTLD).
Martín-Aguilar S; López-Rodríguez E; Puentes-Zarzuela MC
Med Clin (Barc); 2023 Jul; 161(2):86-87. PubMed ID: 37087329
[No Abstract] [Full Text] [Related]
19. Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings.
Hoyt D; Hughes J; Liu J; Ayyad H
Radiol Case Rep; 2024 Jun; 19(6):2168-2182. PubMed ID: 38515768
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
